Optiver Holding
NGNE icon

Optiver Holding’s Neurogene NGNE Stock Holding History

Optiver Holding’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01K Sell
32
-35
-52% -$964 ﹤0.01% 2481
2026
Q1 		$1.35K Buy
67
+6
+10% +$116 ﹤0.01% 1992
2025
Q4 		$1.26K Sell
61
-15
-20% -$373 ﹤0.01% 2166
2025
Q3 		$1.32K Buy
+76
New +$1.53K ﹤0.01% 2469

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Optiver Holding's NGNE Position: Q2 2026 in Review

Optiver Holding reduced its Neurogene (NGNE) stake by 52% in Q2 2026, selling an estimated $964 and leaving 32 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #2481.

Optiver Holding first reported a position in NGNE in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.35K in Q1 2026. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Optiver Holding held 32 shares of Neurogene worth $1.01K as of Q2 2026.
  • Optiver Holding sold 35 Neurogene shares in Q2 2026, an estimated $964.
  • Neurogene made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2481 holding.
  • Optiver Holding first reported a position in Neurogene in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Neurogene position peaked at $1.35K in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.